Antineoplastic potential of mycotoxins

Area of Science:

• * Mycology
• * Toxicology
• * Pharmacology

Background:

• * Fungal toxins, specifically mycotoxins, are diverse secondary metabolites impacting eukaryotic cells.
• * Mycotoxins exhibit a dual nature, possessing harmful genotoxic effects (mutagenic, teratogenic, carcinogenic) alongside beneficial cytotoxic and antineoplastic properties.
• * This "double-edged sword" characteristic suggests potential therapeutic applications, especially in oncology where survival may outweigh mutagenic risks.

Purpose of the Study:

• * To categorize fungal toxins based on their genotoxic and cytotoxic profiles.
• * To identify mycotoxins with potential as combined cytotoxic and antimetastatic agents.
• * To explore the structure-function relationships of antimetastatic mycotoxins.

Main Methods:

• * Classification of mycotoxins into three categories: highly genotoxic, adversely toxic, and antitumorigenic.
• * Preselection of mycotoxins by excluding the highly genotoxic category.
• * Analysis of structural features contributing to cytotoxicity and antimetastatic activity.

Main Results:

• * Mycotoxins were categorized based on their genotoxic and cytotoxic effects.
• * Highly cytotoxic mycotoxins with manageable side effects and antineoplastic properties were identified as potential candidates for combating metastasis.
• * Structural features like ring structures with heteroatoms, functional groups, and oxygen atoms were linked to oxidative stress and cytotoxicity.

Conclusions:

• * Certain mycotoxins, excluding highly genotoxic ones, show promise as antimetastatic agents.
• * The study highlights the potential of utilizing the cytotoxic and antineoplastic properties of specific fungal toxins in cancer therapy.
• * Further research into the structure-function relationship of antimetastatic mycotoxins is warranted to refine their therapeutic application.